Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Medium-term Modulation of the Inflammatory Profile by Medium-cut Off Membranes in Patients With End Stage Renal Disease

NCT03270371 is registered in ClinicalTrials.gov with Technical University of Munich as lead sponsor.

NCT NCT03270371
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03270371 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Medium-term Modulation of the Inflammatory Profile by Medium-cut Off Membranes in Patients With End Stage Renal Disease
Lead sponsor
Technical University of Munich
Phase
Not applicable
Overall status
Unknown status
Start date
September 1, 2017
Completion date
February 28, 2019
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases, end stage renal disease